Bruker (BRKR) Tops Q4 EPS by 1c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 falls from record high as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Bruker Reports Fourth Quarter and Fiscal Year 2021 Financial Results
February 11, 2022 7:00 AM ESTQ4 2021 revenues $683.5M, up 8.9% year-over-year (yoy); organic revenue growth of 11.4% yoy Q4 2021 GAAP EPS $0.50; non-GAAP EPS $0.59, up $0.01 yoy FY 2021 revenues of $2.42B, up 21.7% yoy; organic revenue growth of 19.1% yoy FY 2021 GAAP EPS $1.81; non-GAAP EPS $2.10, up 55.6% yoy Solid organic revenue and non-GAAP EPS growth expected in FY 2022, with significant investments in Project Accelerate 2.0 initiatives, particularly in proteomics, spatial biology, semicon metrology and biopharma
BILLERICA, Mass.--(BUSINESS... More
